全文获取类型
收费全文 | 3077篇 |
免费 | 177篇 |
国内免费 | 2篇 |
出版年
2023年 | 45篇 |
2022年 | 67篇 |
2021年 | 163篇 |
2020年 | 88篇 |
2019年 | 129篇 |
2018年 | 136篇 |
2017年 | 94篇 |
2016年 | 157篇 |
2015年 | 155篇 |
2014年 | 169篇 |
2013年 | 231篇 |
2012年 | 225篇 |
2011年 | 210篇 |
2010年 | 133篇 |
2009年 | 107篇 |
2008年 | 133篇 |
2007年 | 120篇 |
2006年 | 113篇 |
2005年 | 91篇 |
2004年 | 105篇 |
2003年 | 74篇 |
2002年 | 68篇 |
2001年 | 43篇 |
2000年 | 31篇 |
1999年 | 20篇 |
1998年 | 20篇 |
1997年 | 17篇 |
1996年 | 11篇 |
1995年 | 19篇 |
1994年 | 9篇 |
1993年 | 14篇 |
1992年 | 19篇 |
1991年 | 16篇 |
1990年 | 8篇 |
1989年 | 9篇 |
1988年 | 13篇 |
1986年 | 11篇 |
1985年 | 14篇 |
1984年 | 9篇 |
1982年 | 9篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 10篇 |
1978年 | 13篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1974年 | 10篇 |
1973年 | 12篇 |
1969年 | 9篇 |
1968年 | 7篇 |
排序方式: 共有3256条查询结果,搜索用时 437 毫秒
81.
Developing a safe and effective antiviral treatment takes a decade, however, when it comes to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the pandemic. Screening approved antiviral drugs against COVID-19 would speed the process of finding therapeutic treatment. The current study examines commercially approved drugs to repurpose them against COVID-19 virus main protease using structure-based in-silico screening. The main protease of the coronavirus is essential in the viral replication and is involved in polyprotein cleavage and immune regulation, making it an effective target when developing the treatment. A Number of approved antiviral drugs were tested against COVID-19 virus using molecular docking analysis by calculating the free natural affinity of the binding ligand to the active site pocket and the catalytic residues without forcing the docking of the ligand to active site. COVID-19 virus protease solved structure (PDB ID: 6LU7) is targeted by repurposed drugs. The molecular docking analysis results have shown that the binding of Remdesivir and Mycophenolic acid acyl glucuronide with the protein drug target has optimal binding features supporting that Remdesivir and Mycophenolic acid acyl glucuronide can be used as potential anti-viral treatment against COVID-19 disease. 相似文献
82.
83.
Ali Asghar Moghadam Eemaeil Ebrahimie Seyed Mohsen Taghavi Ali Niazi Mahbobeh Zamani Babgohari Tahereh Deihimi Mohammad Djavaheri Amin Ramezani 《Molecular biotechnology》2013,54(3):756-769
A small number of stress-responsive genes, such as those of the mitochondrial F1F0-ATP synthase complex, are encoded by both the nucleus and mitochondria. The regulatory mechanism of these joint products is mysterious. The expression of 6-kDa subunit (MtATP6), a relatively uncharacterized nucleus-encoded subunit of F0 part, was measured during salinity stress in salt-tolerant and salt-sensitive cultivated wheat genotypes, as well as in the wild wheat genotypes, Triticum and Aegilops using qRT-PCR. The MtATP6 expression was suddenly induced 3 h after NaCl treatment in all genotypes, indicating an early inducible stress-responsive behavior. Promoter analysis showed that the MtATP6 promoter includes cis-acting elements such as ABRE, MYC, MYB, GTLs, and W-boxes, suggesting a role for this gene in abscisic acid-mediated signaling, energy metabolism, and stress response. It seems that 6-kDa subunit, as an early response gene and nuclear regulatory factor, translocates to mitochondria and completes the F1F0-ATP synthase complex to enhance ATP production and maintain ion homeostasis under stress conditions. These communications between nucleus and mitochondria are required for inducing mitochondrial responses to stress pathways. Dual targeting of 6-kDa subunit may comprise as a mean of inter-organelle communication and save energy for the cell. Interestingly, MtATP6 showed higher and longer expression in the salt-tolerant wheat and the wild genotypes compared to the salt-sensitive genotype. Apparently, salt-sensitive genotypes have lower ATP production efficiency and weaker energy management than wild genotypes; a stress tolerance mechanism that has not been transferred to cultivated genotypes. 相似文献
84.
Siva S. Panda Mohamed A. Ibrahim Said A. El‐Feky Alan R. Katritzky 《Journal of peptide science》2013,19(2):110-117
Nα‐Boc‐Nim‐(4‐toluenesulfonyl‐l ‐histidylbenzotriazole) enables convenient acylation of N‐, O‐, S‐, and C‐nucleophiles with no detectable racemization. We report efficient syntheses of novel histidine‐containing di‐, tri‐, and tetra‐peptides and models for the preparation of potentially biologically active histidine N‐, O‐, S‐, and C‐conjugates. Copyright © 2013 European Peptide Society and John Wiley & Sons, Ltd. 相似文献
85.
Turan Bayram Oktay Arslan Halil Ibrahim Ugras Umit Cakir Ozen Ozensoy 《Journal of enzyme inhibition and medicinal chemistry》2013,28(6):739-744
The enzyme carbonic anhydrase (E.C. 4.2.1.1) has a stimulatory effect on glaucoma, an eye disease that has a risk to dogs, which are models for the human eye disease, that is similar to that in humans.In this study, some sulfonamide derivatives, 2-(3-cyclohexene-1-carbamido)-1,3,4-thiadiazole-5-sulfonamide (CCTS), 4-(3-cyclohexene-1-carbamido) methyl-benzenesulfonamide (CCBS), 2-(9-octadecenoylamido)-1,3,4-thiadiazole-5-sulfonamide (ODTS), 2-(4,7,10-trioxa-tetradecanoylamido)-1,3,4-thiadiazole-5-sulfonamide (TDTS), and 2-(8-methoxycoumarine-3-carbamido)-1,3,4-thiadiazole-5-sulfonamide (MCTS), as well as some anionic compounds (perchlorate and chloride) and existing medicines (dorzolamide-HCl, gentamicine sulphate, tropicamide, and procaine-HCl) were assayed for their inhibition of dog carbonic anhydrase (dCA), which was purified from erythrocytes on an affinity gel of L-tyrosine-sulfonamide-Sepharose 4B. ODTS showed the highest potency amongst the synthetic compounds with IC50 value 1.18 × 10? 5 M. Amongst the medicines tested, only dorzolamide showed inhibition with IC50 value 5.05 × 10? 4 M. Procaine and tropicamide actually showed an activatory effect, whereas gentamicine sulfate had no significant effect. The inhibitory effects of anionic compounds such as perchlorate and chloride were also investigated; whereas perchlorate showed inhibition, chloride did not. 相似文献
86.
Adel M. Attia Galal H. Elgemeie Ibrahim S. Alnaimi 《Nucleosides, nucleotides & nucleic acids》2013,32(8):1355-1363
Abstract The synthesis of new 4- and 5-substituted-3-cyanopyridine nucleosides has been performed by reacting the silylated pyridines and penta-O-acetyl-α -D-glycopyranose in dichloroethane in the presence of SnCl4. The free nucleosides were tested for their potential activity against HIV and different types of tumor. 相似文献
87.
Miroslav Bobek Pittaya Tuntiwachwuttikul M. Mohsen Ismail Thomas J. Bardos 《Nucleosides, nucleotides & nucleic acids》2013,32(8):1657-1665
Abstract N-Aminopyrazine analogues of cytidine and 2′-deoxycytidine were prepared from 1-(β-D-ribofuranosyl)-1,2-dihydro-2-oxopyrazine and 1-(2-deoxy-β-D-ribofuranosyl)-1,2-dihydro-2-oxopyrazine, respectively, by amination with O-mesitylenesulfonylhydroxylamine. 相似文献
88.
Mohamed F. Abdel-Megeed Mohamed A. Saleh Youssef L. Aly Ibrahim M. Abdo 《Nucleosides, nucleotides & nucleic acids》2013,32(9-10):1985-1996
Abstract A series of some new acetylated S-glycosides of 2-thioxoquinazolin-4-ones, their thiono analogues and 3,1-benzothazin-2,4-dithione derivatives, including a D-glucose and a D-galactose derivatives and a D-xylose, and an L-arabinose derivatives have been synthesized. The conformation and configuration of these carbohydrate derivatives were determined by analysing their 1H and 13C NMR chemical shifts and coupling constants. The biological activity of these compounds has been studied. 相似文献
89.
Abdel Kader Mansour Yehia A. Ibrahim Nasser S. A. M. Khalil 《Nucleosides, nucleotides & nucleic acids》2013,32(10):2265-2283
Abstract The 6-β-arylvinyl-2- and 4-glucosyl-3-thioxo-2,3-dihydro-1,2,4-triazin-5(4H)-ones were synthesized with high selectivity using the recently developed amino protecting group strategy. The structure of these new glucosides was established chemically and spectroscopically. Also, some interesting chemical transformations and rearrangements were observed. 相似文献
90.
Mohammad Hashemi Abdolkarim Moazeni-roodi Farshid Arbabi Aliakbar Fazaeli Ebrahim Eskandari Nasab Mohsen Taheri 《Nucleosides, nucleotides & nucleic acids》2013,32(5):401-410
Several studies have focused on the RAGE genetic background and have demonstrated that its polymorphisms affect the receptor's activity, expression, and downstream signaling. However, there is only little information regarding RAGE polymorphism in breast cancer. In the present study, the authors studied RAGE polymorphisms in 71 patients with breast cancer and 93 healthy women. RAGE –374T/A, –429T/C, and 63 bp Ins/del polymorphisms were analyzed using a hexaprimer amplification refractory mutation system PCR (H-ARMS-PCR). The results showed that RAGE polymorphisms are not associated with breast cancer in the current study population. Larger studies are required to confirm these data in other populations. 相似文献